Stuart Hazeldine
Impact in
- Organic Chemistry top 10%
- Synthesis and Biological Evaluation
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
-
- RNA Interference and Gene Delivery
- Polyamine Metabolism and Applications
- Advanced biosensing and bioanalysis techniques
- Epigenetics and DNA Methylation
- Cancer therapeutics and mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 5
- RNA Interference and Gene Delivery 5
- Advanced biosensing and bioanalysis techniques 2
- Epigenetics and DNA Methylation 2
-
- Synthesis and Biological Evaluation 5
- Quinazolinone synthesis and applications 3
- Co-authors
- Jerome P. Horwitz (8 shared papers)David Oupický (6 shared papers)Thomas H. Corbett (7 shared papers)Lisa Polin (6 shared papers)Kathryn White (6 shared papers)Juiwanna Kushner (6 shared papers)Yu Zhu (5 shared papers)Patrick M. Woster (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (6 papers)Bioorganic & Medicinal Chemistry (3 papers)Investigational New Drugs (2 papers)Molecular Cancer Therapeutics (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- United StatesUnited KingdomSouth Korea
In The Last Decade
Stuart Hazeldine
20 papers receiving 745 citations
Peers
Comparison fields: 5 of 89
- Organic Chemistry 298
- Molecular Biology 408
- Toxicology 16
- Biochemistry 31
- Pharmacology 55
Countries citing papers authored by Stuart Hazeldine
This map shows the geographic impact of Stuart Hazeldine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Hazeldine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Hazeldine more than expected).
Fields of papers citing papers by Stuart Hazeldine
This network shows the impact of papers produced by Stuart Hazeldine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Hazeldine. The network helps show where Stuart Hazeldine may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Hazeldine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 101 | |
| 2 | 2001 | 101 | |
| 3 | 2012 | 79 | |
| 4 | 2002 | 70 | |
| 5 | 2012 | 58 | |
| 6 | 2004 | 54 | |
| 7 | 2008 | 42 | |
| 8 | 2014 | 38 | |
| 9 | 2011 | 29 | |
| 10 | 2006 | 26 | |
| 11 | 2007 | 25 | |
| 12 | 2005 | 22 | |
| 13 | 2005 | 21 | |
| 14 | 2014 | 21 | |
| 15 | 2012 | 19 | |
| 16 | 2012 | 15 | |
| 17 | 2011 | 14 | |
| 18 | 2002 | 13 | |
| 19 | 2002 | 6 | |
| 20 | 2014 | 4 |
About Stuart Hazeldine
Stuart Hazeldine is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Immunology and Cellular and Molecular Neuroscience, having authored 20 papers that have together received 758 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Synthesis and Biological Evaluation (5 papers), RNA Interference and Gene Delivery (5 papers), Chemokine receptors and signaling (3 papers), Quinazolinone synthesis and applications (3 papers), Immunotherapy and Immune Responses (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Organic Chemistry (298 citations), Molecular Biology (408 citations), Toxicology (16 citations), Biochemistry (31 citations) and Pharmacology (55 citations). Stuart Hazeldine has collaborated with scholars based in United States, United Kingdom and South Korea. Frequent co-authors include Jerome P. Horwitz, David Oupický, Thomas H. Corbett, Lisa Polin, Kathryn White, Juiwanna Kushner, Yu Zhu, Patrick M. Woster, Jing Li and Chunying Li. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Investigational New Drugs, Molecular Cancer Therapeutics and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.